Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Bullfrog AI Holdings, Inc. Common Stock
BFRG
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $8.3M
$0.70
▼ -1.24%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$0.43 - $2.04
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 57.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary bfLEAP AI/ML platform for pharmaceutical data analysis
- University licensing agreements with George Washington University and Johns Hopkins University
- Specialized focus on underserved therapeutic areas including obesity, NAFLD, and cancer
- Deep expertise combining artificial intelligence with biopharmaceutical development
Bear Case
1 risk
- Low volatility (beta -2.9).
Growth
Strong growth ahead
Increasing adoption of AI/ML in drug discovery and development
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Falling
-34.6% over 3m
Quality
Thin
Weak fundamentals - proceed with caution
Dividend
None
No dividend
Smart-money signal
Who's buying BFRG right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 12, 2026
MAY 14, 2026
Earnings recap unavailable for this period.
EPS surprise · last 4Q
0 of 1 beats
Q2 26
—
Next: May 12, 2026
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$0
$0
$0
$0
$33.3K
$83.4K
$0
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.